Osteogene Tech Corp., a commercial-stage bone regenerative business, said Aug. 19 that it was selected as one of the early-stage technology companies to receive up to $1 million in matching funding from the New Jersey Economic Development Authority’s Angel Match Program.
The funds will be used to help accelerate the commercialization of the company’s InRoad technology, an FDA-cleared, engineered bioceramic bone graft that leads to natural bone regeneration and restoration promoting blood absorption and circulation.
Osteogene will receive an initial $400,000 investment to help support its commercialization and scale-up efforts. Over the coming months, Osteogene and the NJEDA plan to collaborate on an additional $600,000 in matching funds — bringing the total potential investment to $1 million. The funding will support supply and demand, distribution to dental practices, and further research to discover applications for their patented technology in bone regeneration.
“We are honored to be selected as a recipient of the Angel Match Program and thank the NJEDA for their support and funding, which has brought us one step closer to achieving our goal of improving patients’ lives with our technology, InRoad,” said Dongwoo Sohn, co-founder, president and CEO at Osteogene. “At Osteogene, we remain committed to our vision of transforming the future of bone regeneration through cutting-edge innovation and delivering accessible and effective solutions for both doctors and patients.”
Based in Norwood, Osteogene was founded in 2015 with a mission to transform bone graft technology. Its flagship product, InRoad, was developed by Daniel Oh, co-founder and chief science officer, who leveraged over two decades of research at Columbia University and the University of Texas at San Antonio to bring the groundbreaking technology to market. Following its FDA clearance and the necessary period for patient data collection, InRoad experienced a surge in adoption this year, with sales growing more than 500% from 2024.
The Angel Match Program was designed to disburse funding from the State Small Business Credit Initiative, a federal program administered by the U.S. Department of Treasury. Its purpose is to propel the creation of an entrepreneurial ecosystem that stimulates innovation and economic development, providing employment opportunities for New Jersey residents.
